Julie Wiltse v. HHS - Tdap, Guillain-Barré syndrome (2021)
Case summary [AI summaries can sometimes make mistakes]
Julie Wiltse filed a petition on August 26, 2019, seeking compensation under the National Vaccine Injury Compensation Program. She alleged that she developed Guillain-Barré syndrome (GBS) as a result of receiving a pneumococcal conjugate vaccine and a Tetanus-diphtheria-acellular pertussis (Tdap) vaccine on May 9, 2017.
The respondent, the Secretary of Health and Human Services, denied that the vaccines caused Ms. Wiltse's GBS or any other injury.
Despite maintaining their positions, both parties agreed to settle the case. The court reviewed the file and found the stipulation to be reasonable, adopting it as its decision.
The stipulation awarded Ms. Wiltse a lump sum of $75,000.00 for pain and suffering and an additional $256.16 to reimburse a Medicaid lien.
This award represents compensation for all damages available under the program. The court approved the award and directed that judgment be entered.
Source PDFs
USCOURTS-cofc-1_19-vv-01273